These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 373099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
    Carey M, Blake S.
    Postgrad Med J; 1986 Jul 17; 62 Suppl 1():111-2. PubMed ID: 3317338
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relative value of beta blockers and thiazides for initiating antihypertensive therapy. Beta blockers or thiazides in hypertension.
    Fagard R, Amery A, De Plaen JF, Lijnen P, Missotten A.
    Acta Cardiol; 1976 Jul 17; 31(5):411-26. PubMed ID: 14468
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb 17; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS, Watson OF, Brocklehurst JE.
    Med J Aust; 1979 Jun 30; 1(13):625-6. PubMed ID: 386061
    [Abstract] [Full Text] [Related]

  • 16. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
    Nilsson OR, Karlberg BE, Ohlsson O, Thulin T, Tolagen K.
    Acta Med Scand; 1979 Jun 30; 206(4):303-8. PubMed ID: 506802
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic.
    McAreavey D, Ramsay LE, Latham L, Lorimer AR, McLaren D, Reid JL, Robertson JI, Robertson MP, Weir RJ.
    J Hypertens Suppl; 1983 Dec 30; 1(2):116-9. PubMed ID: 6400110
    [Abstract] [Full Text] [Related]

  • 19. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
    González-Gómez A, García-Barreto D, Gamio Capestany F, Hernández-Cañero A, Fong Chi S.
    Cor Vasa; 1982 Dec 30; 24(6):422-8. PubMed ID: 6764167
    [Abstract] [Full Text] [Related]

  • 20. Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
    Pandhi P, Sharma BK, Sharma PL, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb 30; 23(2):92-4. PubMed ID: 3886568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.